相关实验视频

Updated: Jan 14, 2026

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

检查点抑制剂及其他方面:对皮肤恶性瘤免疫疗法的系统性审查

Yasir Rashid¹, Kartika Devi S², Tomas Faustino Gonzalez-Espinosa³

¹Department of Dermatology, Al-Mustansiriyah University, Baghdad, IRQ.

|January 13, 2026

概括

先进的皮肤癌治疗方法,如免疫检查点抑制剂,显示出显著的益处. 组合疗法提供更高的生存率和反应率,但会增加毒性,需要仔细选择和监测患者以获得最佳结果.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
皮肤病学皮肤病学

背景情况:

皮肤癌是一个主要的健康问题,需要改进治疗策略.
免疫检查点抑制剂 (ICI) 在治疗晚期皮肤恶性瘤方面取得了重大进展.

研究的目的:

评估ICI,内免疫疗法,向药物及其组合在晚期皮肤癌症中的疗效和耐受性.
分析结果,包括无进展生存率 (PFS),客观反应率 (ORR) 和整体生存率 (OS).

主要方法:

一个符合PRISMA的系统审查和对2012年至2024年间发表的26项研究的元分析.
研究包括随机试验,观察队列和评估抗PD-1/PD-L1和抗CTLA-4疗法的网络元分析.
分析包括黑色素瘤,基底细胞癌 (BCC),皮肤状细胞癌 (cSCC) 和默克尔细胞癌 (MCC).

主要成果:

组合疗法在各种皮肤癌的生存率和反应率上始终超过单一疗法.
具体的药物显示出希望:PD-1治疗黑色素瘤,阿维卢马布治疗MCC,以及尼沃卢马布/塞米普利马布治疗cSCC.
向疗法 (BRAF/MEK 抑制剂) 显示出较长的整体存活期,而新兴的策略,如基于 TIL 的免疫疗法显示出持久的反应.

结论:

免疫疗法为晚期皮肤癌提供了实质性的,持久的益处,组合方法显示了增强的疗效.
增加的毒性,特别是严重的免疫相关不良事件 (30-59%),与组合疗法有关.
仔细选择和监测患者至关重要,以平衡这些先进治疗方式的疗效和毒性.

关键词:

: 黑色素瘤是一种黑色素瘤这种药物是BRAF/MEK抑制剂.检查点抑制剂检查点抑制剂皮肤状细胞癌 (CSCC)免疫疗法免疫疗法梅克尔细胞癌 (Merkle cell carcinoma) 是一种癌症.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...